Last updated Nov 17, 2026. 241 unique records for (BPC-157 OR "BPC 157" OR BPC157 OR "body protection compound 157" OR bepecin OR "PL 14736" OR PL14736 OR "PL-14736"). 2026 is a partial year. A large share of the published BPC-157 literature comes from a single research group, and independent replication is limited. Cards on this page do not restate healing or other applied claims. Source on PubMed
RC-BPC · Tissue Signaling Research
RC-BPC
Tissue Signaling Research
Vial sizes for laboratory supply, not a protocol.
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
- Catalog title
- RC-BPC | Tissue Signaling Research
- Research focus
- Tissue Signaling Research
- Also described as
- BPC-157 · body protection compound 157 · bepecin
- Format
- Lyophilized research peptide
- Catalog status
- In stock (public listing)
- Presentations
- 10 mg, 20 mg, and 30 mg lyophilized presentationsCatalog sizes, not a protocol
- Molecular formula
- C62H98N16O22PubChem CID 9941957
- Molecular weight
- 1419.5PubChem average for CID 9941957
- Receptor context
- Described as a synthetic 15-amino-acid peptide whose sequence is derived from a larger protein reported in human gastric juiceLiterature and handbook description; research context only
- Sequence
- Not reproduced hereSee primary literature / PubChem
- Researcher access
- Sign-in required to view pricing
- PubMed records
- 241 uniqueQuery above, Nov 17, 2026
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Tissue Signaling Research
RC-BPC appears in the PEPTIDEA™ Cellular Signaling Research collection with RC-TB4, RC-BPTB4, and RC-KLW.
Narrowly sourced preclinical literature
The great majority of published BPC-157 research is preclinical, and a large share originates from a single research group. Controlled human clinical data are scarce. This page does not treat anecdotal reports as evidence.
Not an approved drug
BPC-157 is not an approved drug in the United States. Catalog notes also record that it appears on the WADA prohibited list. Those are identification facts, not use advice.
10 mg, 20 mg, and 30 mg lyophilized presentations
The public listing is a variable product with 10 mg, 20 mg, and 30 mg presentations of the lyophilized research material. The default control on this page is the 10 mg presentation. Catalog sizes are not a protocol.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
| Catalog title | RC-BPC | Tissue Signaling Research |
|---|---|
| Category | Tissue Signaling Research (Cellular Signaling Research) |
| Associated names | BPC-157; body protection compound 157; bepecin; gastric pentadecapeptide |
| Format | Lyophilized research peptide |
| Public catalog status | In stock (as of Nov 17, 2026) |
| Catalog presentations | 10 mg, 20 mg, and 30 mg lyophilized presentations — sizes of the research material, not a use protocol |
| Molecular formula | C62H98N16O22 (PubChem CID 9941957, retrieved Nov 17, 2026) |
| Molecular weight | 1419.5 (PubChem average for CID 9941957) |
| InChIKey | HEEWEZGQMLZMFE-RKGINYAYSA-N (PubChem) |
| Receptor context | Published papers describe BPC-157 as a synthetic pentadecapeptide derived from a protective protein reported in gastric juice, and as relatively stable in experimental gastric-fluid settings. That is an identity and chemistry description, not a use claim. It is not an approved drug in the United States and appears on the WADA prohibited list. |
| Sequence | Not reproduced on this page. See primary literature and the PubChem record. |
| Pricing | Visible after researcher sign-in |
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
Seiwerth et al.
This review describes BPC 157 as a stable gastric pentadecapeptide and surveys published laboratory work. It is included as identity and literature-context material for the named peptide.
Wound-healing and other applied wording in the review is not restated on this page. A large share of the surveyed work comes from a single research tradition.
Staresinic et al.
This paper studied BPC 157 in a transected rat Achilles-tendon model and in cultured tendocytes. It is a laboratory study, not a clinical trial of this vial.
Healing-model and cell-culture findings in the paper are not restated on this page.
Mateescu et al.
This review discusses BPC-157 as an investigational peptide and surveys biopharmaceutical and formulation challenges reported in the literature. It is included as literature-context material, not as a development or use guide for this catalog item.
Translational, formulation, and any medical-application wording in the review is not reproduced here.
Józwiak et al.
This article reviews published papers and patents concerning BPC 157. It is included as a map of the named-compound literature, not as evidence for a use of this catalog material.
Possible medical-application wording in the review is not restated on this page.
Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query (BPC-157 OR "BPC 157" OR BPC157 OR "body protection compound 157" OR bepecin OR "PL 14736" OR PL14736 OR "PL-14736"). Source on PubMed
Storage & handling
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
- Handle as a lyophilized research material intended for laboratory use only.
- Store according to the conditions printed on the label and in any compound document provided to approved researchers.
- Protect closed vials from moisture and unnecessary temperature swings.
- If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
- This material is not for human or veterinary use and is not medical advice.
Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.





